Glucose Lowering Drugs or Strategies, Major Adverse Cardiovascular Events and Heart Failure Outcomes, and Association with Weight Loss - A Meta-analysis of Large Cardiovascular Outcome Trials
Glucose Lowering Drugs or Strategies, Major Adverse Cardiovascular Events and Heart Failure Outcomes, and Association with Weight Loss - A Meta-analysis of Large Cardiovascular Outcome Trials
批准号:
412251
负责人:
Ghosh-Swaby Olivia R
金额:
$0.07万
依托单位国家:
加拿大
项目类别:
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-09-01 至 2020-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The consistency of diabetes therapies to reduce or increase cardiovascular (CV) risk such as heart failure (HF) or major adverse cardiovascular events (MACE) - stroke, heart attack, or CV death - remains unclear.
We searched online research databases an
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exercise and anti-diabetic drugs to restore brain function in obesity
-
批准号:437270
-
项目类别:Studentship Programs
-
资助金额:$10.93万
-
财政年份:2020
-
负责人:Ghosh-Swaby Olivia R
-
依托单位:
Exercise and anti-diabetic drugs to restore neural stem cells, memory and mood in obesity
-
批准号:439789
-
项目类别:Studentship Programs
-
资助金额:$7.65万
-
财政年份:2020
-
负责人:Ghosh-Swaby Olivia R
-
依托单位:
海外基金